丹麦2004至2016年HIV-1传播簇与耐药突变特征分析
该研究分析丹麦2004至2016年1815例患者的HIV-1 POL序列,描述耐药突变流行率并鉴定传播簇。监测性耐药突变(SDRM)流行率为6.7%,具临床影响的耐药突变(DRM)为12.3%;共识别197个传播簇含706例患者。研究显示活跃传播日益以男男性行为者(MSM)为主,近期SDRM与DRM流行率上升未伴随传播网络内更持续传播。
要点
- 丹麦HIV-1监测性耐药突变流行率6.7%,临床相关耐药突变12.3%。
- 共识别197个传播簇、涉及706例患者,活跃簇以MSM为主。
- SDRM与DRM流行率上升未伴随传播簇内更持续传播。
核心结论
- 丹麦HIV-1活跃传播日益以MSM为主,非B亚型比例逐渐增加。
- 近期SDRM与DRM流行率上升未与传播网络内更持续传播相关联。
研究设计与样本
- 对丹麦2004至2016年1815例患者的HIV-1 POL序列进行亚型、耐药突变及系统发育关系分析。
- 研究描述耐药突变流行率并鉴定传播簇,比较活跃与非活跃簇特征。
主要发现
- 监测性耐药突变(SDRM)流行率为6.7%,具临床影响的耐药突变(DRM)流行率为12.3%。
- 共识别197个传播簇,包含706例患者。
- 40岁及以上患者成为传播簇成员的可能性较低,传播簇内患者境外感染可能性较低。
- 活跃簇较非活跃簇晚presenter(LP)比例更低;大型活跃簇较小活跃簇含更多MSM、成员更多在丹麦感染,LP比例及DRM患者数显著更低。
- 亚型分析显示丹麦HIV流行逐渐更多由非B亚型/循环重组型构成。
临床怎么用
- 可利用传播簇监测识别活跃传播网络,指导针对性干预。
- 应关注MSM人群中HIV传播的动态变化及耐药突变监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study describes the prevalence of human immunodeficiency virus (HIV) drug resistance mutations among 1,815 patients in Denmark from 2004 to 2016 and characterises transmission clusters. POL sequences were analysed for subtype, drug resistance mutations and phylogenetic relationship. The prevalence of surveillance drug resistance mutations (SDRM) was 6.7%, while the prevalence of drug resistance mutations (DRM) with a clinical impact was 12.3%. We identified 197 transmission clusters with 706 patients. Patients 40 years or older were less likely to be members of a transmission cluster and patients in transmission clusters were less likely to be infected abroad. The proportion of late presenters (LP) was lower in active compared with inactive clusters. Large active clusters consisted of more men who have sex with men (MSM), had members more frequently infected in Denmark and contained a significantly lower proportion of LP and significantly fewer patients with DRM than small active clusters. Subtyping demonstrated that the Danish HIV epidemic is gradually becoming more composed of non-B subtypes/circulating recombinant forms. This study shows that active HIV-1 transmission has become increasingly MSM-dominated and that the recent increase in SDRM and DRM prevalence is not associated with more sustained transmission within identified transmission networks or clusters.
引用
- Petersen A, Cowan SA, Nielsen J, et al. Characterisation of HIV-1 transmission clusters and drug-resistant mutations in Denmark, 2004 to 2016. Euro Surveill. 2018. PMID: 30401010. doi:10.2807/1560-7917.ES.2018.23.44.1700633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。